JMD Ventures (511092)
Asset PlayScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹13.12 |
| Market Cap | ₹38.62 Cr |
| P/E Ratio | 16.82 |
| ROCE | 4.19% |
| ROE | 1.89% |
| Dividend Yield | 0% |
| Profit Growth | -45% |
| Debt/Equity | — |
| Sales Growth | -30% |
| 52-Week Range | ₹4.41 — ₹13.12 |
| Sector | Entertainment |
| Book Value | ₹14.07 |
Strengths
- Trading at a slight discount to book value: price ₹13.12 vs book value ₹14.07 (P/B 0.93)
- Small market cap of ₹39 Cr leaves room for a meaningful re-rating if operations revive
- P/E of 16.82 is not extreme if current trough earnings recover
- Positive ROCE of 4.19% shows some capital is earning a return, though modest
Concerns
- Latest quarter sales and net profit are both ₹0 Cr, indicating no current operating earnings
- Sales declined 30% and profit declined 45%, with no sign of stabilisation
- ROE of 1.89% and Piotroski F-Score of 3/9 suggest weak profitability and financial stress
- No dividend and promoter holding not disclosed, leaving investors without cash return or ownership visibility
AI Analysis
This business fails my first test: I want predictable earnings power, not a film venture where every release is a fresh roll of the dice. JMD has revenue shrinking 30%, profits down 45%, and the latest quarter shows literally zero sales and zero profit. That is not a healthy going concern; it is a company waiting for one lucky release. At ₹13.12, the market cap is ₹39 Cr against book value of ₹14.07 per share, so P/B is 0.93. A price slightly below book looks like Graham's margin of safety, but film libraries, receivables, and exhibition assets are not like cash or plant; their realisable value can evaporate quickly. ROE is only 1.89% and ROCE is just 4.19%, far below what a patient owner should accept. The P/E of 16.82 is meaningless when current earnings are near zero. The Piotroski F-Score of 3/9 adds to my worry about financial health, and promoter holding is not even disclosed, so I cannot judge insider alignment. There is no dividend, no growth, and no identifiable moat in an intensely hit-driven industry. The only comfort is the small discount to book value, roughly a 7% cushion. That is not enough. This could be an asset play if dependable liquidation value exists, but film companies rarely liquidate; they keep hoping for one blockbuster. At this price, I am neither a buyer nor a short seller. I would need a much lower price, an honest valuation of the film library, and clarity on capital returns. Until then, this belongs in the 'too hard' pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer